Specialty Overview

Best Hospitals for Sickle Cell Disease Treatment in India

90 hematology hospitals in our India network are listed, across 5 cities (Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai), accredited by JCI, NABH, ISO, NABL, with 51,822 beds combined.

90
Hospitals Listed
5
Cities
4.5
Avg. Rating
5
Accreditation Types
The Short Answer

This page lists the hematology hospitals in our directory offering Sickle Cell Disease Treatment in India, including Nanavati Super Specialty Hospital, Apollo Hospitals, Medanta - The Medicity, Artemis Hospital and others. Hospitals are listed across Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai. Each listing links through to the hospital's full profile page.

Ask us about sickle cell disease treatment in India

Share a few details and our care coordination team will get back to you with next steps.

Top Hospitals for Sickle Cell Disease Treatment in India

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 reviews) 350 beds
Why consider this hospital?
5/5 rating from 12 reviews350 beds
Specialties & Accreditation
OncologyCardiac SurgeryNeurosciencesTransplantBariatrics
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering sickle cell disease treatment can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing sickle cell disease treatment.

5/5
Rating
1950
Established
350
Beds
Mumbai, India
Location
Apollo Hospitals

🇮🇳 Apollo Hospitals

New Delhi, India 4.9 (1240 reviews) 1,000 beds
Why consider this hospital?
4.9/5 rating from 1240 reviews1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering sickle cell disease treatment can be cared for by Apollo Hospitals's care team in New Delhi, India, from initial consultation through recovery. Apollo Hospitals, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing sickle cell disease treatment.

4.9/5
Rating
1983
Established
1,000
Beds
New Delhi, India
Location
Medanta - The Medicity

🇮🇳 Medanta - The Medicity

Gurgaon, India 4.9 (2150 reviews) 1,600 beds
Why consider this hospital?
4.9/5 rating from 2150 reviews1,600 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering sickle cell disease treatment can be cared for by Medanta - The Medicity's care team in Gurgaon, India, from initial consultation through recovery. Medanta - The Medicity, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing sickle cell disease treatment.

4.9/5
Rating
2009
Established
1,600
Beds
Gurgaon, India
Location
Artemis Hospital

🇮🇳 Artemis Hospital

Gurgaon, India 4.9 (64 reviews) 750 beds
Why consider this hospital?
4.9/5 rating from 64 reviews750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering sickle cell disease treatment can be cared for by Artemis Hospital's care team in Gurgaon, India, from initial consultation through recovery. Artemis Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing sickle cell disease treatment.

4.9/5
Rating
2007
Established
750
Beds
Gurgaon, India
Location
Fortis Memorial Research Institute

🇮🇳 Fortis Memorial Research Institute

Gurgaon, India 4.8 (1100 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1100 reviews1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering sickle cell disease treatment can be cared for by Fortis Memorial Research Institute's care team in Gurgaon, India, from initial consultation through recovery. Fortis Memorial Research Institute, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing sickle cell disease treatment.

4.8/5
Rating
1996
Established
1,000
Beds
Gurgaon, India
Location
Kokilaben Dhirubhai Ambani Hospital

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 reviews) 750 beds
Why consider this hospital?
4.8/5 rating from 1800 reviews750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering sickle cell disease treatment can be cared for by Kokilaben Dhirubhai Ambani Hospital's care team in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing sickle cell disease treatment.

4.8/5
Rating
2009
Established
750
Beds
Mumbai, India
Location
Tata Memorial Hospital

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 reviews) 629 beds
Why consider this hospital?
4.8/5 rating from 2500 reviews629 beds
Specialties & Accreditation
OncologyCancer Center
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering sickle cell disease treatment can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing sickle cell disease treatment.

4.8/5
Rating
1941
Established
629
Beds
Mumbai, India
Location
Max Super Specialty Hospital

🇮🇳 Max Super Specialty Hospital

New Delhi, India 4.8 (1300 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 1300 reviews500 beds
Specialties & Accreditation
CardiacLiver Transplant
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering sickle cell disease treatment can be cared for by Max Super Specialty Hospital's care team in New Delhi, India, from initial consultation through recovery. Max Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing sickle cell disease treatment.

4.8/5
Rating
2000
Established
500
Beds
New Delhi, India
Location
Narayana Health

🇮🇳 Narayana Health

Bengaluru, India 4.8 (1750 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1750 reviews1,000 beds
Specialties & Accreditation
CardiacPediatric SurgeryCancer
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering sickle cell disease treatment can be cared for by Narayana Health's care team in Bengaluru, India, from initial consultation through recovery. Narayana Health, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing sickle cell disease treatment.

4.8/5
Rating
2000
Established
1,000
Beds
Bengaluru, India
Location
Yashoda Hospitals, Hi-Tech City

🇮🇳 Yashoda Hospitals, Hi-Tech City

Hi-Tech City, Hyderabad, India 4.8 (742 reviews) 2,000 beds
Why consider this hospital?
4.8/5 rating from 742 reviews2,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsOrgan Transplant
JCIJoint Commission International accreditationNABHNational Accreditation Board for Hospitals & Healthcare Providers accreditation

Patients considering sickle cell disease treatment can be cared for by Yashoda Hospitals, Hi-Tech City's care team in Hi-Tech City, Hyderabad, India, from initial consultation through recovery. Yashoda Hospitals, Hi-Tech City, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing sickle cell disease treatment.

4.8/5
Rating
1989
Established
2,000
Beds
Hi-Tech City, Hyderabad, India
Location

Top Hematology Doctors in India

Dr. Rahul Bhargava Featured

Dr. Rahul Bhargava

MBBS, MD (General Medicine), DM (Clinical Hematology), Advanced Fellowship in Unrelated and Haploidentical Transplant
Principal Director & Chief – Hematology · Specialty: Hematologist & BMT Specialist
Fortis Memorial Research Institute Gurgaon, India20+ Years experience
Why consider this doctor?
  • 20+ years of experience in Hematologist & BMT Specialist
  • Principal Director – Hemato-Oncology, Fortis Memorial Research Institute, Gurugram
  • Head of Hematology and BMT, Artemis Hospital, Gurugram
Expertise & Procedures
  • Autologous Bone Marrow Transplant
  • Allogeneic Bone Marrow Transplant
  • Haploidentical BMT
  • Unrelated Donor BMT
  • Peripheral Blood Stem Cell Transplantation
View all procedures →
Hematologist & BMT Specialist Experience: 20+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Image not available

Dr. Arun Singh Danewa

MBBS, MD (Pediatrics), Pediatric Oncology Training, Fellowship in Bone Marrow Transplantation
Sr. Consultant — Pediatric Hematology, Oncology & BMT · Specialty: Pediatric Hematologist & BMT Specialist
Artemis Hospital Gurgaon, India10+ Years experience
Why consider this doctor?
  • 10+ years of experience in Pediatric Hematologist & BMT Specialist
  • Senior Consultant — Pediatric Hematology, Oncology, Bone Marrow Transplant, Artemis Hospital, Gurugram
  • Pediatric Oncology Fellowship, Sir Ganga Ram Hospital, New Delhi
Expertise & Procedures
  • Allogeneic Bone Marrow Transplant
  • Autologous Bone Marrow Transplant
  • Haploidentical Stem Cell Transplant
  • Matched Sibling Donor Transplant for Thalassemia
  • Bone Marrow Aspiration & Biopsy
View all procedures →
Pediatric Hematologist & BMT Specialist Experience: 10+ YearsHospital Affiliation: Artemis HospitalHospital accreditation: JCI, NABH
Image not available

Dr. Gaurav Dixit

MBBS, MD (General Medicine), DM (Clinical Haematology), Professional Certificate in Multiple Myeloma
Head — Haematology Oncology & Bone Marrow Transplant (Unit II) · Specialty: Hematologist & BMT Specialist
Artemis Hospital Gurgaon, India17+ Years experience
Why consider this doctor?
  • 17+ years of experience in Hematologist & BMT Specialist
  • Head — Haematology Oncology & Bone Marrow Transplant (Unit II), Artemis Hospital, Gurugram
  • Senior Consultant — Haematology & BMT, Action Cancer Hospital, Delhi
Expertise & Procedures
  • Autologous Stem Cell Transplant
  • Matched Sibling Allogeneic Stem Cell Transplant
  • Haploidentical Stem Cell Transplant
  • Matched Unrelated Donor Transplant
  • Bone Marrow Aspiration & Biopsy
View all procedures →
Hematologist & BMT Specialist Experience: 17+ YearsHospital Affiliation: Artemis HospitalHospital accreditation: JCI, NABH
Image not available

Dr. Vikas Dua

MBBS, MD (Paediatrics), FNB (Paediatric Hematology Oncology), Fellowship in Paediatric Bone Marrow Transplant, Outreach Programme in Paediatric BMT
Principal Director & Head — Paediatric Haematology, Haemato-Oncology & BMT · Specialty: Pediatric Hematologist & BMT Specialist
Fortis Memorial Research Institute Gurgaon, India20+ Years experience
Why consider this doctor?
  • 20+ years of experience in Pediatric Hematologist & BMT Specialist
  • Principal Director & Head — Paediatric Haematology, Haemato-Oncology and BMT, Fortis Memorial Research Institute, Gurgaon
  • Senior Consultant — Paediatric Hemato-Oncology and BMT, Artemis Hospital, Gurgaon
Expertise & Procedures
  • Allogeneic Bone Marrow Transplant
  • Matched Sibling Donor Transplant
  • Matched Unrelated Donor Transplant
  • Haploidentical Paediatric Stem Cell Transplant
  • Autologous Stem Cell Transplant
View all procedures →
Pediatric Hematologist & BMT Specialist Experience: 20+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Rayaz Ahmed

Dr. Rayaz Ahmed

MBBS, MD (Pathology), DM (Clinical Hematology)
Director — Hematology & Bone Marrow Transplantation · Specialty: Hematologist & BMT Specialist
Max Super Speciality Hospital, Saket New Delhi, India20+ Years experience
Why consider this doctor?
  • 20+ years of experience in Hematologist & BMT Specialist
  • Director — Hematology & Bone Marrow Transplantation, Max Super Speciality Hospital, Saket, New Delhi
  • Senior Consultant — Department of Hematology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi
Expertise & Procedures
  • Autologous bone marrow / peripheral blood stem cell transplant
  • Allogeneic matched sibling donor stem cell transplant
  • Haplo-identical stem cell transplant
  • Matched unrelated donor stem cell transplant
  • Bone marrow aspiration and biopsy
View all procedures →
Hematologist & BMT Specialist Experience: 20+ YearsHospital Affiliation: Max Super Speciality Hospital, SaketHospital accreditation: NABH, JCI
Image not available

Dr. Ajay Gupta

MBBS, MD, DM, FRACP, Fellowship in Pediatric Bone Marrow Transplantation, Fellowship in Leukemia and Bone Marrow Transplantation
Senior Consultant — Hematology · Specialty: Hematologist & Bone Marrow Transplant Specialist
Indraprastha Apollo Hospital New Delhi, India17+ Years experience
Why consider this doctor?
  • 17+ years of experience in Hematologist & Bone Marrow Transplant Specialist
  • Senior Consultant — Hematology, Indraprastha Apollo Hospital, New Delhi — Present
  • Specialist in Bone Marrow Transplantation and Leukemia Management — Indraprastha Apollo Hospital, New Delhi
Expertise & Procedures
  • Allogeneic Bone Marrow Transplantation
  • Autologous Stem Cell Transplantation
  • Haploidentical Bone Marrow Transplantation
  • Peripheral Blood Stem Cell Mobilization and Harvesting
  • Pediatric Bone Marrow Transplantation
View all procedures →
Hematologist & Bone Marrow Transplant Specialist Experience: 17+ YearsHospital Affiliation: Indraprastha Apollo HospitalHospital accreditation: JCI, NABH
Our Methodology

How we selected these hospitals

A hospital appears on this page when Hematology is among its listed specialties and it is located in India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Sickle Cell Disease Treatment in India?

Choosing the right hospital for sickle cell disease treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include hematology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Sickle Cell Disease Treatment

Sickle Cell Disease (SCD) is a severe inherited hemoglobinopathy requiring lifelong, multidisciplinary management — from hydroxyurea therapy and chronic transfusion programs to potentially curative allogeneic Bone Marrow Transplantation (BMT).

BMT: 30–45 days in-hospital (conditioning + engraftment + early monitoring); Hydroxyurea/Crisis Care: 5–10 days per acute admission
Hospital Stay
BMT: 3–6 months in-country (immune reconstitution monitoring required before international travel); Hydroxyurea initiation / Crisis Care only: 2–4 weeks
Total Stay in Country (Fit-to-Fly)
BMT (matched sibling donor, pediatric): 85–92% event-free survival; Hydroxyurea response rate: 70–80% reduction in vaso-occlusive crisis frequency
Success Rate

Clinical Overview

  • Sickle Cell Disease is caused by a point mutation in the HBB gene (Glu6Val), resulting in the production of hemoglobin S (HbS).
  • Under conditions of hypoxia, dehydration, or acidosis, HbS polymerizes, distorting red blood cells into a rigid, sickle-shaped morphology.
  • These cells obstruct microvasculature, triggering vaso-occlusive crises (VOC), acute chest syndrome (ACS), splenic sequestration, and chronic end-organ damage affecting the kidneys, lungs, brain, liver, and retina.
Full details →

Who is a Candidate?

  • **Eligible for Allogeneic BMT (Curative Intent):**
  • Children and young adults (ideally under 16 years; adult BMT up to age 40–45 at experienced centers) with severe SCD (HbSS or HbSβ⁰-thalassemia genotype)
  • History of ≥2 acute chest syndrome episodes, ≥1 clinical stroke or silent cerebral infarct on MRI, recurrent severe VOC (≥3 hospitalizations/year despite hydroxyurea), chronic transfusion dependency, or progressive sickle nephropathy
  • Availability of an HLA-matched sibling donor (10/10 match preferred; haploidentical protocols expanding eligibility)
  • +24 more

Treatment Options & Approaches

  • **1.
  • Hydroxyurea (Hydroxycarbamide) Therapy — Disease Modification**

Recovery

  • **Phase 1 — Remote Pre-Assessment (Weeks 1–3, from home country)**

Risks to be aware of

  • Patients and families must be counseled on the following procedure-specific risks before committing to any SCD treatment pathway.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides a fully integrated medical travel management service covering every non-clinical dimension of the patient's journey to India or the UAE.

Common questions about Sickle Cell Disease Treatment

What is the cost of Sickle Cell Disease Treatment — Hydroxyurea, BMT & Crisis Care — in India vs. the UAE?
The cost varies significantly based on the treatment pathway selected. For Allogeneic Bone Marrow Transplantation (BMT), the total cost in India typically ranges from USD 18,000 to USD 40,000, covering pre-transplant workup, conditioning chemotherapy, stem cell infusion, a 30–45 day hospital stay, early post-transplant monitoring, and standard medications including GvHD prophylaxis agents (tacrolimus, methotrexate, ATG). In the UAE (Dubai/Abu Dhabi), an equivalent BMT program costs approximately USD 45,000 to USD 90,000 at JCI/DHA-accredited centers such as Cleveland Clinic Abu Dhabi or King's College Hospital Dubai. For hydroxyurea initiation and medical management without BMT, costs in India range from USD 2,000–6,000 per treatment episode, versus USD 5,000–12,000 in the UAE. Acute vaso-occlusive crisis management (hospitalization, IV opioid analgesia, exchange transfusion if required) costs approximately USD 1,500–4,000 per episode in India and USD 4,000–9,000 per episode in the UAE. India offers JCI and NABH-accredited transplant centers with outcome data equivalent to international benchmarks at 50–60% lower cost than the UAE. The UAE offers premium facilities, luxury patient rooms, and seamless access for patients flying from the Middle East and East Africa. Both destinations include BMT-specific inclusions: HLA typing, pharmacokinetically dosed conditioning, engraftment monitoring, and chimerism analysis. Costs are indicative; GAF Healthcare provides a personalized cost estimate within 48 hours of receiving the patient's medical records.
How long do I need to stay in India or the UAE before I am fit to fly home after Sickle Cell Disease treatment?
The required in-country stay depends entirely on the treatment pathway. For patients undergoing Allogeneic Bone Marrow Transplantation (BMT), the minimum safe in-country stay is 90 days, and most transplant protocols recommend 120–180 days (4–6 months) before international air travel is approved. This extended stay is clinically essential: the first 100 days post-transplant are the highest-risk period for graft failure, severe acute GvHD, and life-threatening opportunistic infections (CMV, invasive aspergillosis, Pneumocystis pneumonia). The treating hematologist will clear the patient for international travel only when: (1) neutrophil and platelet engraftment is stable and sustained, (2) donor chimerism is ≥95% on two consecutive assessments, (3) immunosuppression is being tapered without GvHD flare, (4) no active infection is present, and (5) the patient can access equivalent emergency hematology/transplant care within their home country. For patients treated only with hydroxyurea initiation or acute crisis management without BMT, the required stay is much shorter — typically 2–4 weeks. This allows time for the treating team to confirm hydroxyurea dose tolerability (ANC and platelet response at Week 2–3), complete post-crisis clinical stability assessment, and prepare a detailed outpatient management plan for the home-country physician. GAF Healthcare coordinates a fit-to-fly certification letter from the treating physician and arranges medical escort services for BMT patients requiring in-flight medical supervision on the return journey if residual immunosuppression or clinical fragility warrants it.
What is the success rate of Sickle Cell Disease treatment — particularly BMT — in India and the UAE?
Success rates for Sickle Cell Disease treatment differ significantly by treatment modality and must be interpreted carefully. For Allogeneic BMT using a matched sibling donor (MSD) in pediatric patients (under 16 years), leading Indian transplant centers (Apollo, Tata Memorial, Narayana Health) and UAE centers (Cleveland Clinic Abu Dhabi) report event-free survival (EFS) rates of 85–92% at 5 years, with overall survival (OS) of 90–95%. These outcomes are consistent with published data from the European Group for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR). In adult SCD patients (16–40 years), EFS is slightly lower at 75–85% with MSD BMT, due to higher rates of GvHD and treatment-related complications. Haploidentical (half-matched donor) BMT, now performed at advanced centers in India and the UAE using post-transplant cyclophosphamide protocols, reports EFS of 60–75% — a significant improvement in patients who lack a fully matched donor. For hydroxyurea therapy, clinical response is defined as a ≥50% reduction in annualized vaso-occlusive crisis rate and/or ACS episodes, achieved in approximately 70–80% of patients who reach maximum tolerated dose and maintain compliance. Hemoglobin F levels rise from a baseline of 5–8% to 15–25% in responders, substantially reducing HbS polymerization and disease severity. For emerging gene therapy approaches (betibeglogene spartivec, exagamglogene autotemcel), early trial data show transfusion independence in >90% of treated patients at 2-year follow-up, though long-term durability data (>5 years) are still maturing. GAF Healthcare only partners with centers that publish and can demonstrate transparent outcome data, including transplant-related mortality rates, GvHD incidence, and engraftment success rates, so patients can make fully informed decisions.

How GAF Healthcare Assists in Choosing the Best Hospital for Sickle Cell Disease Treatment in India

Discover the Top Hospitals for Sickle Cell Disease Treatment in India

This page lists 90 accredited hematology hospitals in India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Patient Success Story

Iraqi Family's Journey: Baby Ibrahim's Life-Saving Heart Surgery in India
Common Questions

Frequently asked questions about sickle cell disease treatment in India

How many hematology hospitals are listed in India?
90 hospitals in our India directory are currently listed for hematology including Sickle Cell Disease Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Hematology is among its listed specialties and it is located in India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Which cities in India have hematology hospitals listed?
Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai. Use the city links on this page to view hospitals in a specific city.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, ISO, NABL — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for sickle cell disease treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about sickle cell disease treatment in India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for sickle cell disease treatment in India.

Contact us to report an inaccuracy on this page.